̽��ֱ��

̽��ֱ��UK is a world leader in sequencing SARS-CoV-2, the virus that causes COVID-19. Of all the coronavirus genomes that have been sequenced in the world, nearly half have been sequenced by COVID-19 Genomics UK Consortium (Cog-UK). ̽��ֱ��consortium began life on 4 March 2020 when Sharon Peacock, a professor of public health and microbiology at the ̽��ֱ�� of Cambridge, emailed a handful of scientists and asked for their help.

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

In late 2019, a new institute opened on the Cambridge Biomedical Campus. Its timing could not have been better - as the COVID-19 pandemic sent Britain into lockdown several months later, the institute found itself at the heart of the ̽��ֱ��’s response to this unprecedented challenge.

A ‘pill on a string’ test can identify ten times more people with Barrett’s oesophagus than the usual GP route, after from a 3-year trial were published in the medical journal  ̽��ֱ��Lancet.